Risk factors for resistance to proton pump inhibitor maintenance therapy for reflux esophagitis in Japanese women over 60 years

Digestion. 2012;86(4):323-8. doi: 10.1159/000342393. Epub 2012 Nov 1.

Abstract

Aim: The aim of this study was to evaluate risk factors for proton pump inhibitor (PPI) resistance in older Japanese female patients with reflux esophagitis evaluated by physicians.

Methods: The study included 462 Japanese female patients aged over 60 years with reflux esophagitis who received PPI maintenance therapy for more than 6 months.

Results: The characteristics of all 462 patients were: age: 76.4 ± 7.6 years, height: 147.2 ± 6.1 cm, weight: 49.9 ± 8.4 kg and body mass index: 24.0 ± 3.5. The reflux esophagitis grades were A in 69.5%, B in 15.8%, C in 9.1% and D in 5.6%. Helicobacter pylori was positive in 60.6%. Regarding PPI maintenance therapy for clinical symptoms evaluated by the attending physicians, 66.7% were 'good control', 26.8% were 'reasonable control' and 6.5% were 'bad control: resistant'. PPI maintenance therapy was less effective in patients with more severe reflux esophagitis of grades C and D (OR: 0.027; 95% CI: 0.010-0.077) and negative H. pylori infection status (OR: 4.470; 95% CI: 1.631-12.247). Lumbar kyphosis and hiatus hernia were risk factors for severity grading of reflux esophagitis.

Conclusions: PPI maintenance therapy evaluated by attending physicians indicated that reflux esophagitis severity and negative H. pylori status were risk factors for treatment resistance.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Analysis of Variance
  • Confidence Intervals
  • Drug Resistance*
  • Esophagitis, Peptic / complications
  • Esophagitis, Peptic / drug therapy*
  • Female
  • Helicobacter Infections / complications*
  • Helicobacter pylori
  • Hernia, Hiatal / complications
  • Humans
  • Japan
  • Kyphosis / complications
  • Lumbar Vertebrae
  • Maintenance Chemotherapy
  • Middle Aged
  • Odds Ratio
  • Proton Pump Inhibitors / therapeutic use*
  • Risk Factors
  • Severity of Illness Index

Substances

  • Proton Pump Inhibitors